TENX – tenax therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

TENX

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/13

07:00 am

tenx

Tenax Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

Neutral Report

Tenax Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

Report

10/31

04:05 pm

tenx

Tenax Therapeutics to Present at the Guggenheim Healthcare Innovation Conference

Low Report

Tenax Therapeutics to Present at the Guggenheim Healthcare Innovation Conference

Report

10/25

06:46 am

tenx

Tenax Therapeutics, Inc. (NASDAQ: TENX) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.

Medium Report

Tenax Therapeutics, Inc. (NASDAQ: TENX) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.

Report

10/24

07:16 am

tenx

Tenax Therapeutics, Inc. (NASDAQ: TENX) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $16.00 price target on the stock.

High Report

Tenax Therapeutics, Inc. (NASDAQ: TENX) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $16.00 price target on the stock.

Report

10/14

07:56 am

tenx

Tenax Therapeutics, Inc. (NASDAQ: TENX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $16.00 price target on the stock.

Medium Report

Tenax Therapeutics, Inc. (NASDAQ: TENX) is now covered by analysts at Guggenheim. They set a "buy" rating and a $16.00 price target on the stock.

Report

9/30

08:15 am

tenx

Tenax Therapeutics, Inc. (NASDAQ: TENX) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.

Medium Report

Tenax Therapeutics, Inc. (NASDAQ: TENX) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.

Report

9/26

02:11 am

tenx